-transparent.png){kind=logo}
The development of carbohydrate based anti-cancer vaccines is of high current interests. Herein, the latest development in this exciting field is reviewed. After a general introduction about tumor associated carbohydrate antigens and immune responses, the review is focused on the various strategies that have been developed to enhance the immunogenecity of these antigens. The results from animal studies and clinical trials are presented.
| UI | MeSH Term | Description | Entries |
|---|
Related Publications
Zhaojun Yin, and
Xuefei Huang
December 2009,
Current opinion in chemical biology,
Zhaojun Yin, and
Xuefei Huang
July 2019,
Biotechnology letters,
Zhaojun Yin, and
Xuefei Huang
March 2012,
Yao xue xue bao = Acta pharmaceutica Sinica,
Zhaojun Yin, and
Xuefei Huang
June 2009,
Current opinion in chemical biology,
Zhaojun Yin, and
Xuefei Huang
November 2022,
Bioorganic & medicinal chemistry,
Zhaojun Yin, and
Xuefei Huang
March 2012,
Future medicinal chemistry,
Zhaojun Yin, and
Xuefei Huang
December 2020,
Drug discovery today. Technologies,
Zhaojun Yin, and
Xuefei Huang
July 2022,
Pharmacology & therapeutics,
Zhaojun Yin, and
Xuefei Huang
July 2015,
Chemistry (Weinheim an der Bergstrasse, Germany),
Zhaojun Yin, and
Xuefei Huang
April 2016,
Virologica Sinica,
